Ourself complexion brightening serum

(Carlsbad, CA) Ourself launched the Complexion Brightening Serum, a major advancement in biotech skincare for reducing and preventing skin discoloration.

Key ingredients and technology:

Patented MI9™ Peptide: Helps inhibit pigment formation by blocking the melanocyte at the source before it forms, by binding to the MC1 receptor.

Tiered-Release Vesicle™ (TRV™) Delivery: patented technology that enhances the penetration and efficacy of Tranexamic Acid (TXA) deeper into the skin.

Tranexamic Acid (TXA): Helps diminish the appearance of discoloration linked to inflammation.

Other Actives: 4-Butylresorcinol, stabilized vitamin C, Retinyl Linoleate, and Niacinamide target multiple pathways of uneven skin tone.

Clinical efficacy:

Clinically proven to deliver visibly brighter, more even-toned skin, fast.

Reduced melanin by 38% in 14 days in a controlled human skin model.

68% of subjects saw visible improvement in brown spots in 2 weeks.

87% saw improvement in skin discoloration and brown spots in a subject assessed study.

100% of patients showed improvement in global skin smoothness by Week 12.

Innovation: The serum's combined approach of blocking new pigment (MI9™) and enhancing delivery (TRV™ with TXA) is considered a breakthrough by clinicians.

Company Status: The USPTO issued a patent for MI9™, expanding Ourself's patent portfolio and strengthening its position in clinical innovation and biotech beauty. Ourself is known for its patented TRV™ technology for delivering larger molecules deeper into the skin.

Source Ourself